sr 46349b has been researched along with clopidogrel in 1 studies
| Studies (sr 46349b) | Trials (sr 46349b) | Recent Studies (post-2010) (sr 46349b) | Studies (clopidogrel) | Trials (clopidogrel) | Recent Studies (post-2010) (clopidogrel) |
|---|---|---|---|---|---|
| 51 | 1 | 7 | 10,221 | 1,918 | 5,951 |
| Protein | Taxonomy | sr 46349b (IC50) | clopidogrel (IC50) |
|---|---|---|---|
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.562 | |
| P2Y purinoceptor 12 | Homo sapiens (human) | 2.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernat, A; Dol, F; Herbert, JM; Rinaldi, M; Sainte-Marie, M | 1 |
1 other study(ies) available for sr 46349b and clopidogrel
| Article | Year |
|---|---|
Potentiating effect of clopidogrel and SR 46349, a novel 5-HT2 antagonist, on streptokinase-induced thrombolysis in the rabbit.
Topics: Animals; Bleeding Time; Clopidogrel; Drug Synergism; Fibrinolytic Agents; Fluorobenzenes; Jugular Veins; Male; Phenols; Platelet Aggregation Inhibitors; Rabbits; Serotonin Antagonists; Streptokinase; Thrombolytic Therapy; Thrombosis; Ticlopidine | 1993 |